Taylor Wealth Management Partners’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.91M Sell
60,766
-4,133
-6% -$110K 1.09% 32
2022
Q1
$1.75M Sell
64,899
-7,883
-11% -$141K 0.71% 43
2021
Q4
$1.4M Sell
72,782
-2,233
-3% -$56K 0.49% 41
2021
Q3
$2.48M Buy
75,015
+2,330
+3% +$71.2K 0.89% 38
2021
Q2
$2.41M Buy
72,685
+867
+1% +$24K 0.85% 40
2021
Q1
$2.98M Sell
71,818
-9,777
-12% -$301K 1.09% 37
2020
Q4
$1.62M Buy
81,595
+498
+0.6% +$7.37K 0.62% 42
2020
Q3
$1.12M Buy
81,097
+6,085
+8% +$104K 0.51% 40
2020
Q2
$1.34M Sell
75,012
-8,368
-10% -$131K 0.68% 39
2020
Q1
$1.01M Buy
+83,380
New +$1.4M 0.62% 36

Other funds holding TMDX

Taylor Wealth Management Partners's TMDX Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Transmedics (TMDX) stake by 6.4% in Q2 2022, selling an estimated $110K and leaving 60,766 shares worth $1.91M. The position accounts for 1.09% of the portfolio, ranked #32.

Taylor Wealth Management Partners first reported a position in TMDX in Q1 2020 and has held it in 10 quarters since. The position peaked at $2.98M in Q1 2021. 134 funds tracked by Wall St. Rank hold TMDX as of Q2 2022.

  • Taylor Wealth Management Partners held 60,766 shares of Transmedics worth $1.91M as of Q2 2022.
  • Taylor Wealth Management Partners sold 4,133 Transmedics shares in Q2 2022, an estimated $110K.
  • Transmedics made up 1.09% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #32 holding.
  • Taylor Wealth Management Partners first reported a position in Transmedics in Q1 2020 and has held it in 10 quarters since.
  • Taylor Wealth Management Partners's Transmedics position peaked at $2.98M in Q1 2021.
  • 134 funds tracked by Wall St. Rank held Transmedics as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.